News | August 16, 2023
Exor to buy 15% shareholding in Philips
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Good momentum in commercial CDMO business
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
Subscribe To Our Newsletter & Stay Updated
